Sitavig

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

132 API Suppliers, 33 USDMF, 19 CEP/COS, 8 JDMF, 16 EU WC, 36 KDMF, 26 NDC API, 52 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

402 FDF Dossiers, 98 FDA Orange Book, 122 Europe, 17 Canada, 19 Australia, 30 South Africa, 116 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 5%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 6 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 36 BASF, 3 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 3 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 39 Disintegrants & Superdisintegrants, 37 Thickeners and Stabilizers, 28 Direct Compression, 27 Granulation, 26 Topical, 23 Coating Systems & Additives, 23 Solubilizers, 18 Film Formers & Plasticizers, 16 Controlled & Modified Release, 16 Lubricants & Glidants, 16 Co-Processed Excipients, 12 Parenteral, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 8 Emulsifying Agents, 6 Rheology Modifiers, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 113 Regulatory FDF Prices

MARKET PLACE

41 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Sitavig

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Gangwal Chemicals

filter Capability Reset all filters

filter Country Reset all filters

01

Gangwal Chemicals

FUJISIL

Specialty & Agro Chemical

Not Confirmed

Looking for Sitavig? Find API Stability Enhancers used in Sitavig to address drug delivery challenges on PharmaCompass.

Sitavig

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

132 API Suppliers

33 USDMF

19 CEP/COS

8 JDMF

16 EU WC

36 KDMF

26 NDC API

52 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

402 FDF Dossiers

98 FDA Orange Book

122 Europe

17 Canada

19 Australia

30 South Africa

116 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 5%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

6 SPI Pharma

11 DKSH

6 Faran Shimi Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

4 ACG Worldwide

5 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

36 BASF

3 Corel Pharma Chem

6 DFE Pharma

2 Esteem Industries

2 Finar

9 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

22 Kerry

1 Kima Chemical

3 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qualicaps

27 Roquette

3 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

1 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

CAPSULE;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUSPENSION;ORAL - 200MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons